Macular degeneration affects more than 15 million Americans. More than 2 million Americans age 50 and older have late-stage AMD. AMD diagnoses have increased 25 percent since 2000, and the number of people affected by AMD is expected to increase even more as the population ages, according to Prevent Blindness America and the National Eye Institute.
“The IMT is making big headlines because so many people are affected by AMD,” Pang said. “For end-stage AMD, this is potentially the only viable treatment option for patients. We are excited to offer new hope for patients with AMD.”
Dr. Pang said that having the new treatment option available in Southern California is important, but cautioned that not all patients who have AMD are eligible for it. There are specific criteria for the implantable telescope and many factors to consider when deciding whether a patient is a good candidate for it.
“Being a rehabilitation center for this new technology, and having a treatment option for end-stage AMD, will be great for the Eye Care Center for many reasons,” Pang said. “This also will allow our students to learn how to manage patients with end-stage AMD. By getting them involved, they will better understand what’s available for their patients, which teaches them what services and resources they need and helps them understand the interprofessional team approach needed to manage these patients.”
Approximately 50 provider team locations are available across the country; three
Copyright©2012 Vocus, Inc.
All rights reserved